
		From Wikipedia, the free encyclopedia
		
		
		
		
		Jump to navigation
		Jump to search
		Korean biotechnology company
.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}Seegene Inc.Native name㈜씨젠TypePublicTraded asKRX: 096530IndustryLaboratory equipment, biotechnology, healthcareFounded2000Key peopleDr. Chun Jong-Yoon (CEO), Lee Ho (President), Kim Bum-Joon (Vice President)Revenue US$957 million (2020)[1]Number of employees793Websiteseegenetech.com
Seegene, Inc is a Korean manufacturer of in vitro diagnostic (IVD) products, particularly molecular diagnostics. Its portfolio includes a range of assays and screening products for sepsis, respiratory diseases such as influenza and respiratory syncytial virus, as well as sexually transmitted infections (STIs). It was founded in 2000. In early 2020, it began developing and distributing a range of tests for SARS-CoV-2, the virus that causes COVID-19.[2]
Along with its headquarters in Seoul, South Korea, the company has subsidiaries in the U.S.A., Canada, Germany, Italy, Mexico, Brazil, and the Middle East.
In September 2010, Seegene undertook a $16.6M initial public offering to list on KOSDAQ, a trading board of Korea Exchange (KRX).[3]

Contents

1 Products
2 The COVID-19 Pandemic
3 Controversy
4 References



Products[edit]
Seegene’s primary product focus is multiplex diagnostic assays, which allow for the detection and quantification of multiple pathogens from a single sample.[4] Seegene’s assays are developed using its proprietary Dual Priming Oligonucleotide (DPO™), Tagging Oligonucleotide Cleavage and Extension (TOCE™), and Multiple Detection Temperatures (MuDT™) technology platforms. Additional technologies[5] include the GeneFishing™ discovery platform for differentially expressed genes (DEG), which detects differences in gene expression between two or more samples, as well as DNA Walking Technology™, a platform permitting the identification of unknown sequences of DNA situated upstream or downstream of known sequences.[6]

The COVID-19 Pandemic[edit]
Seegene moved quickly in January 2020 to begin developing a diagnostic for what would later be dubbed COVID-19, leveraging its proprietary artificial intelligence technology and SARS-CoV-2 genetic details that had been released online.[7][8] The company produced its first real-time polymerase chain reaction (real-time PCR) assay to test for the novel coronavirus on February 3, 2020.[9] The test, known as the Allplex™ 2019-nCoV Assay, identifies three different target genes – the E, RdRP, and N genes – in one reaction tube. This allows for accurate and high-volume testing when paired with automated instruments.[10]
On February 12, 2020, the Ministry of Food and Drug Safety (MFDS) granted Seegene emergency use authorization for the Allplex 2019-nCoV Assay. The authorization came just days before the COVID-19 pandemic in South Korea began accelerating, centered around the southeastern city of Daegu.
Seegene began manufacturing and distributing up to 100,000 tests per day, cutting back production on 60 other tests to channel resources towards COVID-19.[11] By April 2020, when the U.S. FDA granted emergency use authorization for the assay, the company had sold more than 10 million of the tests in more than 60 countries.[12] Seegene was one of the top-performing Korean companies in 2020, registering profit growth of more than 1,000% year-over-year in the third quarter.[13]
In early 2021, Seegene announced it had developed a first-of-its-kind COVID-19 variant test, the Allplex SARS-CoV-2 Variants I Assay, capable of screening for COVID-19 infection and identifying multiple mutant variations in a single reaction.[14] The company scaled its production to 300,000 variant diagnostic test kits per month, enough to test 30 million people. The tests were subsequently shipped to approximately 20 countries around the world.

Controversy[edit]
In February 2021, Seegene was disciplined by Korea’s Securities and Futures Commission for accounting errors and deficiencies taking place in the company’s early years of operation.[15] According to a company statement, Seegene acknowledged and reconciled those issues in 2019, overhauling its accounting and management practices.

References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}"Seegene spearheading Korea's biotech drive". Retrieved 17 October 2021.

^ "Seegene speeds up exporting Covid-19 test kits". KBR (in Korean). 2021-04-22. Retrieved 2021-08-10.

^ "Seegene Completes $16.6M Korean IPO to Fund Expansion of MDx Kits in the U.S. and Japan". Genetic Engineering and Biotechnology News. 2010-09-14. Retrieved 2021-08-10.{{cite web}}:  CS1 maint: url-status (link)

^ "Seegene's molecular diagnosis leads the way in South Korea's COVID response". euronews. 2020-11-23. Retrieved 2021-08-11.

^ "Patents Assigned to Seegene, Inc. - Justia Patents Search". patents.justia.com. Retrieved 2021-08-11.

^ "Seegene, Inc. Awarded Patent for ACP (Annealing Control Primer)". BioSpace. Retrieved 2021-08-11.

^ Jeong-yeo, Lim (2020-12-14). "[News Focus] COVID-19 'star' Seegene posts tenfold jump in revenue". The Korea Herald. Retrieved 2021-10-18.

^ "How One Firm's Covid-19 Tests Help Control The Virus In South Korea". Forbes. Retrieved 2021-10-18.{{cite web}}:  CS1 maint: url-status (link)

^ Booth, By Ivan Watson, Sophie Jeong, Julia Hollingsworth and Tom (2020-03-12). "How this South Korean company created coronavirus test kits in three weeks". CNN. Retrieved 2021-08-10.

^ Cho, Joohee. "South Korea's coronavirus test makers in high demand". ABC News. Retrieved 2021-10-18.{{cite web}}:  CS1 maint: url-status (link)

^ Jung-a, Song; White, Edward; Yoon, June (2020-04-06). "South Korea's factories stretched to limit churning out virus tests". Financial Times. Retrieved 2021-10-18.

^ "FDA Issues Emergency Use Authorization for Seegene Coronavirus PCR Assay". Genomeweb. 2020-04-21. Retrieved 2021-08-10.

^ Bird, Mike (2021-02-11). "Covid-19's Corporate Winners Should Beware a Push for Profit-Sharing". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-10-18.

^ Reuters Staff (2021-02-01). "S.Korea's Seegene develops first COVID-19 test kit that can detect multiple variants". Reuters. Retrieved 2021-08-10.

^ "Seegene vows to prevent recurrence of accounting fraud". koreatimes. 2021-02-09. Retrieved 2021-08-10.


.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}show.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vte KRX 100 companies of South Korea
Alteogen
AmoreG
AmorePacific
Celltrion
Celltrion Healthcare
Celltrion Pharm
CJ CheilJedang
CJ ENM
Coway
DSME
Doosan Bobcat
Doosan Heavy Industries & Construction
EcoPro BM
Emart
Fila Holdings
F&F
Green Cross
GS
GS Engineering & Construction
GS Retail
Hana Financial
Hanjin KAL
Hankook Tire
Hanmi Pharmaceutical
Hanmi Science
Hanon Systems
Hanwha Solutions
HMM
HLB
Hotel Shilla
Hybe
Hyundai Engineering & Construction
Hyundai Heavy Industries
Hyundai Heavy Industries Holdings
Hyundai Glovis
Hyundai Mobis
Hyundai Motor Company
Hyundai Steel
Iljin Materials
Industrial Bank of Korea
Kakao
KakaoBank
Kakao Games
KakaoPay
Kangwon Land
KB Financial
KEPCO
Kia
Korea Aerospace Industries
Korea Investment
Korea Zinc
Korean Air
Krafton
KSOE
KT
KT&G
Kumho Petrochemical
LG
LG Chem
LG Display
LG Electronics
LG Household & Health Care
LG Innotek
LG Uplus
Lotte
Lotte Chemical
Mirae Asset Securities
Naver
NCsoft
Netmarble
OCI
Pan Ocean
Pearl Abyss
POSCO
POSCO Chemical
S-Oil
Samsung Biologics
Samsung C&T
Samsung Electro-Mechanics
Samsung Electronics
Samsung Engineering
Samsung Fire & Marine
Samsung Heavy Industries
Samsung Life
Samsung SDI
Samsung SDS
Samsung Securities
Seegene
Shinhan Financial
Shin Poong Pharmaceutical
SK
SK Biopharmaceuticals
SK Bioscience
SKC
SK Hynix
SK IE Technology
SK Innovation
SK Square
SK Telecom
Woori Financial
Yuhan





<img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" />
Retrieved from "https://en.wikipedia.org/w/index.php?title=Seegene&oldid=1066739668"
		Categories: Biotechnology companies of South KoreaCompanies listed on the Korea ExchangeManufacturing companies based in SeoulSouth Korean companies established in 2000Hidden categories: Pages with non-numeric formatnum argumentsCS1 Korean-language sources (ko)CS1 maint: url-statusArticles with short descriptionShort description matches WikidataAC with 0 elements
	